Recently, non-small cell lung cancer (NSCLC), breast cancer and pancreatic ductal adenocarcinoma have been showed to overexpress RABL6, and that was closely correlated with poor prognosis [6–9]. The gene discussed is RABL6; the disease is pancreatic ductal adenocarcinoma.